 |
 |
|
|
|
RESÚMENES ABRIL 2010 |
Other Neuropsychiatric
Disorders & General Information
(Haga un click en la
información del journal
para acceder al resúmen)
5
– doble-ciego o
metanálisis; 4 – subanálisis o estudio
aleatorizado; 3
– revisión, abierto, básico; 2 –
casos; 1 – opinión
GRATIS = Texto
gratuito en algunos países de la región iberoamericana
3 -
Action of Modafinil—Increased Motivation Via the Dopamine Transporter
Inhibition and D1 Receptors?
Jared W. Young and Mark A. Geyer
Biological Psychiatry. Volume
67, Issue 8, 15 April 2010, Pages 784-787
3 - Estimation of Plasma IC50 of Donepezil for Cerebral
Acetylcholinesterase Inhibition in Patients With Alzheimer Disease Using
Positron Emission Tomography
Ota,
Tsuneyoshi; Shinotoh, Hitoshi; Fukushi, Kiyoshi; Kikuchi, Tatsuya; Sato,
Koichi; Tanaka, Noriko; Shimada, Hitoshi; Hirano, Shigeki; Miyoshi, Michie;
Arai, Heii; Suhara, Tetsuya; Irie, Toshiaki
Clinical Neuropharmacology:
March/April 2010 - Volume 33 - Issue 2 - pp 74-78
3 - Treatment Effects of Gabapentin for Primary Insomnia
Lo,
Hsiao-Sui; Yang, Chien-Ming; Lo, Helen G; Lee, Chien-Ying; Ting, Hua; Tzang,
Bor-Show
Clinical Neuropharmacology:
March/April 2010 - Volume 33 - Issue 2 - pp 84-90
3 -
Gabapentin
Toxicity in Patients with Chronic Kidney Disease: A Preventable Cause of
Morbidity
Ladan Zand, Kevin P. McKian and Qi Qian
The American Journal of
Medicine. Volume 123, Issue 4, April 2010, Pages 367-373
3! - Allopregnanolone reverses neurogenic and
cognitive deficits in mouse model of Alzheimer's disease
Jun
Ming Wang,
Chanpreet
Singh,
Lifei
Liu,
Ronald
W. Irwin,
Shuhua
Chen,
Eun
Ji Chung,
Richard
F. Thompson,
and Roberta
Diaz Brinton
PNAS April 6, 2010 vol. 107 no. 14 6498-6503
4 - Effects of Rivastigmine in Alzheimer's Disease Patients with and
Without Hallucinations
Jeffrey Cummings, Murat Emre, Dag Aarsland, Sibel
Tekin, Nalina Dronamraju, Roger Lane
Journal
of Alzheimer's Disease. Volume 20, Number 1 / 2010: 301-311
3! - Predictive Factors of Discontinuation and Switch of Cholinesterase
Inhibitors in Community-Dwelling Patients with Alzheimer's Disease: A 2-Year
Prospective, Multicentre, Cohort Study
Gardette,
Virginie; Andrieu, Sandrine; Lapeyre-Mestre, Maryse; Coley, Nicola; Cantet,
Christelle; Ousset, Pierre-Jean; Grand, Alain; Monstastruc, Jean-Louis; Vellas,
Bruno
CNS Drugs: 1 May 2010 - Volume
24 - Issue 5 - pp 431-442
5< - A randomized double-blind placebo-controlled trial of treatment as
usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep
disturbance and depressed mood
Serfaty,
Marc Antony; Osborne, Debbie; Buszewicz, Marta J; Blizard, Robert; Raven, Peter
W
International
Clinical Psychopharmacology: May 2010 - Volume 25 - Issue 3 - pp 132-142
GRATIS 3! - Superior efficacy of new medicines?
Johan C. F. van Luijn,
Frank W. J. Gribnau and Hubert G. M. Leufkens
European Journal of Clinical Pharmacology. Volume 66,
Number 5 / May, 2010: 445-448
3 - Overview of extracellular microvesicles in drug metabolism
Javier Conde-Vancells, Esperanza Gonzalez, Shelly C Lu,
Jose M Mato Professor & Juan M Falcon-Perez
Expert
Opinion on Drug Metabolism & Toxicology. May., 2010, Vol. 6, No. 5, Pages
543-554
3 - P-glycoprotein related drug interactions: clinical importance and a
consideration of disease states
Caroline
A Lee, Jack A
Cook
Expert
Opinion on Drug Metabolism & Toxicology. May., 2010, Vol. 6, No. 5, Pages
603-619
3 - An overview of investigational antiapoptotic drugs with potential
application for the treatment of neurodegenerative disorders
Antoni Camins, Francesc
Xavier Sureda, Felix Junyent, Ester
Verdaguer, Jaume Folch, Carlos
Beas-Zarate & Merce Pallas
Expert Opinion on Investigational Drugs. May., 2010, Vol. 19, No. 5, Pages 587-604
5< - Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic
low back pain
Marianna Mazza, Osvaldo
Mazza,
Costanza
Pazzaglia, Luca Padua
& Salvatore
Mazza
Expert
Opinion on Pharmacotherapy. May., 2010, Vol. 11, No. 7, Pages 1049-1052
GRATIS 3! - The State of Pharmacogenetics Customizing Treatments
Anil K. Malhotra
Psychiatric Times
2010. Vol. 27 No. 4
GRATIS 3 - Tetrabenazina
en los trastornos del movimiento
M. Martín-Carrasco
PSICOGERIATRÍA 2010; 2 (1): 3-14
3 - Treatment of Mental Disorders in
Patients with Parkinson's Disease
U. Meincke, C. M. Kosinski
Fortschr
Neurol Psychiatr 2010; 78(5): 279-287
5< - A Randomized, Double-Blind,
Placebo-Controlled Trial of Olanzapine in the Treatment of Trichotillomania
Michael
Van Ameringen, Catherine Mancini, Beth Patterson, Mark Bennett, and Jonathan
Oakman
Gratis 3 - Role and rationale for the use of milnacipran in the
management of fibromyalgia
Jay D
Kranzler, R Michael Gendreau
Neuropsychiatric Disease and Treatment.
April 2010 , Volume 2010:6
5 -
Systematic Review with Metaanalysis: Comparative Efficacy and Harms of
Duloxetine, Milnacipran, and Pregabalin in Fibromyalgia Syndrome
Winfried
Häuser, Frank Petzke and Claudia Sommer
The Journal of Pain. Article in Press, April 2010
3 -
Valproic acid stimulates clusterin expression in human astrocytes: Implications
for Alzheimer's disease
Tapio Nuutinen, Tiina Suuronen, Anu Kauppinen and Antero Salminen
Neuroscience
Letters. Volume
475, Issue 2, 14 May 2010, Pages 64-68
| Regresar a RESÚMENES ABRIL 2010 |
©
1999-2010 Jorge M Tamayo, MD, BMSS
Creada en Enero 1999
| Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA |